How Identity Evolves in the Age of Genetic Imperialism
By Eleonore Pauwels and Jim Dratwa,
Scientific American
| 03. 13. 2015
From designer babies to women whose genitals smell like peaches, 2014 graced us with a taste of the hope, hype and superficiality of business as usual in Silicon Valley. It is tempting to listen to those who tell us that there is a gene-hack to solve every “problem”—that DNA is just a code to personalize at will.
This brand of genetic determinism has invaded all realms of life, from our dating scene to our social networks. 23andMe genetic-test results flourish on Facebook and OkCupid. Better still, the online-dating platform SingldOut matches partners based on the personality traits supposedly determined by their DNA. Even a recent study from Yale University concluded that our friends resemble us genetically. To cap it off, a subfield of political science now studies the heritability of temperamental and personality traits, which influence political values and decision-making. This becomes more sobering when one considers that scientists at Mount Sinai Hospital in New York are investigating the genetic cause of suicide in the hope of developing suicide DNA tests.
This is politics, love and death...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...